KDR and atherosclerosis: As a crucial modulator of VEGFR2, the reduction of RCAN1.1 and RCAN1.4 might be protective for atherosclerosis by inhibiting VEGFR2 mediated VEGF signaling (Fig. 2) (Alghanem et al. 2017).